I just saw a patient today who had been on the receiving end of this marketing and generally thought that taking a supplement that said GLP-1 support could replace her actual GLP-1 medication, said Beverly Tchang, an associate professor of clinical medicine at Weill Cornell Medicine, and former medical adviser at Novo and Lilly
Diagnostic and prognostic capabilities of various indicators of oxidative stress and antioxidant defense potential (total antioxidant capacity, F2-isoprostanes, oxygen radical absorbance capacity, glutathione peroxidase, malonedialdehyde, advanced glycation end products, and protein oxidation products etc.) in stroke are being intensively studied [5,6,7,8]
One promising aspect of incretin-based dual agonist therapy (e.g., tirzepatide) is that it might offer an alternative to stringent dietary restriction, and could challenge the success of bariatric surgery in the diabesity community.
Connexin-based signaling and drug-induced hepatotoxicity
Who knows
Risk of drug interactions (for example, hypoglycemia or low blood sugar if you take other medications like insulin or metformin)
